Li Ying, Liu Wenqing, Yu Yue, Wang Ya, Zou Liwei, Liu Deyun, Sun Ying
Department of Maternal, Child and Adolescent Health, School of Public Health, Ministery of Education Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Hefei, Anhui, China.
Department of Pediatrics, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Breast Cancer Res. 2025 Sep 1;27(1):158. doi: 10.1186/s13058-025-02116-4.
The age of thelarche in girls has declined globally. While earlier menarche has been linked to higher breast density - a known risk factor for breast cancer - the association between earlier thelarche and breast density remains unclear.
114 Girls presenting with idiopathic central precocious puberty without medication (ICPP), early thelarche (ET), and normal age at thelarche (NT) were recruited from pediatric endocrine clinics of three hospitals during the year of 2020-2021 in Hefei, Anhui Province, China and were followed up for 3-5 years. Participants had their breast composition measured by MRI at 1-year post menarche. Fasting blood samples were collected at baseline and follow-up to measure of reproductive hormone concentrations.
The ET group and ICPP group exhibited significantly higher percent fibroglandular volume (%FGV: 42.1%, 52.0% ) and fibroglandular volume (FGV: 183.3 cm, 237.0cm) compared with the NT group (%FGV: 34.7%, FGV: 148.8cm) . Serum estrogen levels at baseline and follow-up were elevated in the ET group relative to the NT group (52.1 vs. 40.7 pg/ml; 46.1 vs. 38.6 pg/ml), but did not differ significantly from the ICPP group (baseline: 54.6 vs. 52.1 pg/ml; follow-up: 48.9 vs. 46.1 pg/ml). Each 1-year earlier onset of thelarche was associated with a 7.8% increase in %FGV and a 35.7 cm³ increase in FGV. The combined hormonal pathway mediated the association between early puberty (age at thelarche < 9 years) and %FGV in this study, accounting for 28.7% (95% CI: 8.6% - 51.3%) of the total mediation effect. For the association between early puberty and FGV, baseline estradiol mediated 27.7% (95% CI: 11.8% - 44.8%), the pathway from baseline to follow-up estradiol mediated 13.6% (95% CI: 5.0% - 24.3%), and the combined hormonal pathway mediated 45.8% (95% CI: 18.1% - 68.0%).
In this cohort study, earlier thelarche (even between 8.0 and 9.0 years) was associated with higher %FGV and FGV. Prolonged estrogen exposure may represent a modifiable mediator that could be targeted for breast cancer prevention strategies in girls with earlier puberty.
全球范围内女孩乳房发育的年龄有所下降。虽然初潮提前与较高的乳腺密度相关——乳腺密度是已知的乳腺癌风险因素——但乳房发育提前与乳腺密度之间的关联仍不清楚。
2020年至2021年期间,在中国安徽省合肥市的三家医院的儿科内分泌诊所招募了114名未接受药物治疗的特发性中枢性性早熟(ICPP)、乳房早发育(ET)和乳房发育年龄正常(NT)的女孩,并对她们进行了3至5年的随访。参与者在初潮后1年通过MRI测量乳房组成。在基线和随访时采集空腹血样以测量生殖激素浓度。
与NT组(纤维腺体体积百分比[%FGV]:34.7%,纤维腺体体积[FGV]:148.8cm³)相比,ET组和ICPP组的纤维腺体体积百分比(%FGV:42.1%,52.0%)和纤维腺体体积(FGV:183.3cm³,237.0cm³)显著更高。ET组基线和随访时的血清雌激素水平相对于NT组升高(52.1对40.7 pg/ml;46.1对38.6 pg/ml),但与ICPP组无显著差异(基线:54.6对52.1 pg/ml;随访:48.9对46.1 pg/ml)。乳房发育每提前1年,%FGV增加7.8%,FGV增加35.7cm³。在本研究中,联合激素途径介导了青春期提前(乳房发育年龄<9岁)与%FGV之间的关联,占总中介效应的28.7%(95%CI:8.6%-51.3%)。对于青春期提前与FGV之间的关联,基线雌二醇介导27.7%(95%CI:11.8%-44.8%),从基线到随访雌二醇的途径介导13.6%(95%CI:5.0%-24.3%),联合激素途径介导45.8%(95%CI:18.1%-68.0%)。
在这项队列研究中,乳房发育提前(即使在8.0至9.0岁之间)与较高的%FGV和FGV相关。雌激素暴露时间延长可能是一个可改变的中介因素,可作为青春期提前女孩乳腺癌预防策略的目标。